AveX­is sci­en­tif­ic founder fires back at No­var­tis CEO Vas Narasimhan, 'cat­e­gor­i­cal­ly de­nies any wrong­do­ing'

Bri­an Kas­par’s head was among the first to roll at No­var­tis af­ter com­pa­ny ex­ecs be­came aware of the fact that ma­nip­u­lat­ed da­ta had been in­clud­ed in its ap­pli­ca­tion for Zol­gens­ma, now the world’s most ex­pen­sive ther­a­py.

But in his first pub­lic re­sponse, the sci­en­tif­ic founder at AveX­is — ac­quired by No­var­tis for $8.7 bil­lion — is fir­ing back. And he says that not on­ly was he not in­volved in any wrong­do­ing, he’s ready to de­fend his name as need­ed.

I reached out to Bri­an Kas­par af­ter No­var­tis put out word that he and his broth­er Allen had been axed in mid-May, two months af­ter the com­pa­ny be­came aware of the al­le­ga­tions re­lat­ed to ma­nip­u­lat­ed da­ta. His re­sponse came back through his at­tor­neys.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER